Marion Tonneau

<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors

Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian et al. · OncoImmunology · 2022 · 29 citations · Full text

Life Sciences, Microbiology, Oncology +17

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Édouard Auclin, José Carlos Benítez, Marco Tagliamento et al. · Lung Cancer · 2023 · 27 citations · Full text

Medicine, Immunology, Oncology +15

Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study

Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau et al. · Scientific Reports · 2023 · 23 citations · Full text

Pharmacy, Oncology, Radiology +17

A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study

Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau et al. · Cancers · 2023 · 18 citations · Full text

Medicine, Oncology, Radiology +17

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy

Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein et al. · Cancer Treatment and Research Communications · 2023 · 18 citations · Full text

Medicine, Oncology, Immunotherapy +6